We are live on ! Find out more
WM

WS Management Portfolio holdings

AUM $1.13B
1-Year Est. Return 53.44%
This Fund
S&P 500
This Quarter Est. Return
+12.3%
1 Year Est. Return
+53.44%
3 Year Est. Return
+163.58%
5 Year Est. Return
+226.76%
10 Year Est. Return
+868.14%
AUM
$1.65B
AUM Growth
-$403M
Cap. Flow
-$583M
Cap. Flow %
-35.33%
Top 10 Hldgs %
61.25%
Holding
85
New
7
Increased
6
Reduced
52
Closed
20

Top Buys

Rank Stock Value
1
HRTX icon
Heron Therapeutics
HRTX
+$12M
2
KNX icon
Knight Transportation
KNX
+$7.01M
3
URBN icon
Urban Outfitters
URBN
+$6.34M
4
AAPL icon
Apple
AAPL
+$5.44M

Top Sells

Rank Stock Value
1
MU icon
Micron Technology
MU
+$149M
2
TSLA icon
Tesla
TSLA
+$117M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$61.9M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$28.3M
5
SC
SANTANDER CONSUMER USA HOLDINGS INC
SC
+$27.9M

Sector Composition

Rank Sector Weight
1 Financials 33.44%
2 Consumer Discretionary 11.5%
3 Industrials 8.82%
4 Communication Services 8.75%
5 Technology 7.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QURE icon
51
uniQure
QURE
$2.67B
$3.6M 0.22%
60,304
-8,096
-12% -$362K
GRUB
52
PUT
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
$3.13M 0.19%
+22,500
New +$3.49M
BLUE
53
DELISTED
bluebird bio
BLUE
$2.83M 0.17%
1,391
-187
-12% -$329K
WVE icon
54
Wave Life Sciences
WVE
$1.15B
$2.68M 0.16%
68,977
-9,417
-12% -$382K
AUD
55
DELISTED
Audacy, Inc.
AUD
$2.35M 0.14%
446,981
-20,512
-4% -$136K
RGNX icon
56
CALL
Regenxbio
RGNX
$630M
$2.04M 0.12%
35,600
+11,800
+50% +$585K
RARE icon
57
Ultragenyx Pharmaceutical
RARE
$2.67B
$1.77M 0.11%
25,528
-3,444
-12% -$197K
CLLS
58
Cellectis
CLLS
$286M
$1.5M 0.09%
81,772
-11,021
-12% -$195K
SGMO
59
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$1.23M 0.07%
129,372
-17,368
-12% -$177K
AMRS
60
DELISTED
Amyris Inc.
AMRS
$1.15M 0.07%
550,319
-78,785
-13% -$311K
EDIT icon
61
Editas Medicine
EDIT
$416M
$1.13M 0.07%
46,270
-6,244
-12% -$141K
NTLA icon
62
Intellia Therapeutics
NTLA
$1.51B
$1.1M 0.07%
64,168
-8,630
-12% -$129K
ABEO icon
63
Abeona Therapeutics
ABEO
$350M
$1.09M 0.07%
5,930
-796
-12% -$142K
CRSP icon
64
CRISPR Therapeutics
CRSP
$4.66B
$1.08M 0.07%
30,316
-4,081
-12% -$141K
ADAP
65
DELISTED
Adaptimmune Therapeutics
ADAP
$798K 0.05%
185,537
-24,922
-12% -$116K
AAPL icon
66
PUT
Apple
AAPL
$4.93T
– –
-400,000
Closed -$15.8M
BABA icon
67
Alibaba
BABA
$273B
– –
-11,800
Closed -$1.98M
CI icon
68
Cigna
CI
$77.4B
– –
-23,436
Closed -$4.45M
CLW icon
69
Clearwater Paper
CLW
$280M
– –
-183,307
Closed -$4.47M
CMG icon
70
CALL
Chipotle Mexican Grill
CMG
$42.4B
– –
-1,475,000
Closed -$12.7M
CPB icon
71
Campbell Soup
CPB
$6.74B
– –
-133,254
Closed -$4.4M
CVNA icon
72
PUT
Carvana
CVNA
$45.4B
– –
-389,500
Closed -$2.55M
MHK icon
73
Mohawk Industries
MHK
$7B
– –
-33,471
Closed -$3.92M
MPT
74
Medical Properties Trust
MPT
$2.91B
– –
-687,677
Closed -$11.1M
REGN icon
75
CALL
Regeneron Pharmaceuticals
REGN
$70.6B
– –
-29,500
Closed -$11M
1 2
3
4

Similar funds

OHIF
Oriental Harbor Investment Fund Hong Kong $1.13B AUM 70.63% 1-Year Est. Return
HMCP
Hook Mill Capital Partners New York $1.13B AUM 31.32% 1-Year Est. Return
SAM
SP Asset Management Cupertino, California $1.13B AUM 12.57% 1-Year Est. Return
AT
American Trust Lexington, Kentucky $1.13B AUM 17.56% 1-Year Est. Return
ACM
Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return
IP
Indivisible Partners Clearwater, Florida $1.13B AUM
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
PL
Parkwood LLC Cleveland, Ohio $1.13B AUM 32.89% 1-Year Est. Return

WS Management's Q1 2019 Portfolio in Review

As of Q1 2019, WS Management held 85 positions worth $1.65B, down 20% from $2.05B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

WS Management withdrew a net $583M in Q1 2019, closing 20 positions and reducing 52 holdings. Its most notable exit was Tesla, an estimated $117M position sold in full.

By sector, the portfolio is most concentrated in Financials at 33% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, WS Management opened a new position in Heron Therapeutics worth $11.2M.

  • WS Management's largest Q1 2019 buy was Heron Therapeutics: 457,203 shares worth $11.2M.
  • WS Management added most to Urban Outfitters in Q1 2019, an estimated $6.34M increase.
  • WS Management's biggest Q1 2019 reduction was Micron Technology, cutting an estimated $149M.
  • WS Management fully exited Tesla in Q1 2019, selling an estimated $117M.
  • WS Management's ten largest holdings make up 61% of its $1.65B portfolio in Q1 2019.
  • WS Management opened 7 new positions and closed 20 in Q1 2019.
  • WS Management's portfolio value fell 20% quarter-over-quarter to $1.65B.

Based on WS Management's 13F filing for Q1 2019, filed 13 May 2019.